Literature DB >> 6266358

Inhibition and induction of microsomal enzymes in rat. A comparative study of four antimycotics: miconazole, econazole, clotrimazole and ketoconazole.

C J Niemegeers, J C Levron, F Awouters, P A Janssen.   

Abstract

The interaction of four imidazole antimycotics clotrimazole, econazole, ketoconazole and miconazole with other drugs was studied in in vivo models known to reveal inhibition and induction of microsomal enzymes. In rats the duration of methohexital hypnosis and the prothrombin time prolongation induced by acenocoumarol were changed after oral administration of all four antimycotics. The oral ED50-values of miconazole, econazole and clotrimazole for prolongation of methohexital hypnosis in female rats (acute inhibiton of microsomal enzymes) were 3.55, 3.56 and 10.7 mg/kg. Ketoconazole, inhibited microsomal enzymes at the oral ED50 of 30.4 mg/kg in female and 97.0 mg/kg in male rats. After subchronic treatment only clotrimazole reduced the hypnosis time below control values (induction of microsomal enzymes); the ED50 of clotrimazole for his activity was 14.9 mg/kg. The lowest effective dose of ketoconazole for extra-prolongation of the prothrombin time was 50 mg/kg, whereas the other antimycotics showed this effect at much lower doses. The implications of these results for the therapeutic use of these compounds are discussed and it is concluded that ketoconazole can be considered to be devoid of interaction with drugs, of which the intensity and duration of action strongly depends on their metabolic transformation rate in the liver.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6266358

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  16 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

Review 2.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.

Authors:  A D'mello; R Venkataramanan; M Satake; S Todo; S Takaya; R J Ptachcinski; G J Burckart; T E Starzl
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1989-06

5.  Cyclosporin A: pharmacologic activity on the immune system and effects in clinical organ transplantation.

Authors:  L H Block; P M Sutter; M J Mihatsch
Journal:  Klin Wochenschr       Date:  1983-11-02

6.  D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy.

Authors:  G Heinemeyer; I Roots; P Lestau; H R Klaiber; R Dennhardt
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

Review 7.  Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.

Authors:  B Holmes; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

8.  Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.

Authors:  E Sampol; B Lacarelle; J F Rajaonarison; J Catalin; A Durand
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

9.  Disposition of ketoconazole, an oral antifungal, in humans.

Authors:  C Brass; J N Galgiani; T F Blaschke; R Defelice; R A O'Reilly; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

Review 10.  Clinical pharmacokinetics of ketoconazole.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.